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Introduction {#jah31742-sec-0004}
============

Binding of ouabain, one of the cardiotonic steroids, to the Na/K‐ATPase α1 subunit stimulates multiple protein kinase signaling cascades. One of the downstream effects of ouabain‐stimulated Na/K‐ATPase signaling is Ras‐dependent superoxide‐related reactive oxygen species (ROS) generation, which is an integrated component of ouabain‐mediated Na/K‐ATPase signaling.[1](#jah31742-bib-0001){ref-type="ref"}, [2](#jah31742-bib-0002){ref-type="ref"} We have reported that cardiotonic steroids stimulate ROS generation in different in vitro and in vivo models and also that increases in H~2~O~2~ activate Na/K‐ATPase signaling pathways and promote Na/K‐ATPase endocytosis.[1](#jah31742-bib-0001){ref-type="ref"}, [2](#jah31742-bib-0002){ref-type="ref"}, [3](#jah31742-bib-0003){ref-type="ref"}, [4](#jah31742-bib-0004){ref-type="ref"}, [5](#jah31742-bib-0005){ref-type="ref"}, [6](#jah31742-bib-0006){ref-type="ref"}, [7](#jah31742-bib-0007){ref-type="ref"}, [8](#jah31742-bib-0008){ref-type="ref"}

The effect of ROS on the Na/K‐ATPase activity has been well documented.[9](#jah31742-bib-0009){ref-type="ref"}, [10](#jah31742-bib-0010){ref-type="ref"}, [11](#jah31742-bib-0011){ref-type="ref"}, [12](#jah31742-bib-0012){ref-type="ref"} Oxidative modification, such as glutathionylation of cysteine residue(s) of the Na/K‐ATPase α1 subunit[11](#jah31742-bib-0011){ref-type="ref"} and β1 subunit,[10](#jah31742-bib-0010){ref-type="ref"} inhibits the Na/K‐ATPase activity by either stabilizing the enzyme in an E2‐prone conformation or by blocking the ATP‐binding site. We have reported that while ouabain stimulates ROS generation via the Ras/Rac cascade of the Na/K‐ATPase signaling pathways, increases in ROS also activate the Na/K‐ATPase signaling, allowing the formation of a Na/K‐ATPase/Src/ROS signaling amplification loop.[1](#jah31742-bib-0001){ref-type="ref"}, [2](#jah31742-bib-0002){ref-type="ref"}, [3](#jah31742-bib-0003){ref-type="ref"}, [4](#jah31742-bib-0004){ref-type="ref"}, [5](#jah31742-bib-0005){ref-type="ref"}, [6](#jah31742-bib-0006){ref-type="ref"}, [8](#jah31742-bib-0008){ref-type="ref"}, [13](#jah31742-bib-0013){ref-type="ref"} Recently, we have further demonstrated that ROS causes direct protein carbonylation of Pro222 of the actuator (A) domain of the α1 subunit of Na/K‐ATPase in pig LLC‐PK1 cells.[6](#jah31742-bib-0006){ref-type="ref"} This carbonylation modification process is dependent on c‐Src activation as demonstrated by using the Src‐deficient SYF and c‐Src reconstituted SYF+c‐Src cells.[6](#jah31742-bib-0006){ref-type="ref"} Functionally, ouabain and increases in H~2~O~2~ stimulate Na/K‐ATPase signaling, protein carbonylation, and redistribution of Na/K‐ATPase and NHE3, leading to the inhibition of active transepithelial ^22^Na^+^ flux.[6](#jah31742-bib-0006){ref-type="ref"}

Our in vitro data suggest that protein carbonylation of Na/K‐ATPase α1 subunit may be a novel regulatory mechanism of Na/K‐ATPase signaling. However, the functional role of Pro222 carbonylation in the Na/K‐ATPase signaling is unclear. We report here that mutation of Pro224 (as Pro222 in pig α1) to Ala in the rat α1 subunit does not affect ouabain‐induced inhibition of the Na/K‐ATPase activity, but the mutation abolishes ouabain‐induced Na/K‐ATPase signaling, protein carbonylation, endocytosis of the Na/K‐ATPase, and inhibition of active transepithelial ^22^Na^+^ transport. Taken together, we suggest that Pro224 of rat α1 dictates the renal proximal tubule (RPT) Na/K‐ATPase signaling and sodium transport, and that carbonylation modification of Pro224 functions as a signaling amplifier of Na/K‐ATPase signaling.

Materials and Methods {#jah31742-sec-0005}
=====================

Chemicals and Antibodies {#jah31742-sec-0006}
------------------------

All chemicals, except otherwise mentioned, were obtained from Sigma‐Aldrich (St. Louis, MO). Monoclonal antibodies against Na/K‐ATPase α1 subunit (clone α6F and clone C464.6) and β1 (clone C464.8) were from the Developmental Studies Hybridoma Bank at the University of Iowa (Iowa City, IA) and EMD Millipore Upstate (Billerica, MA), respectively. Polyclonal anti‐rat α1‐specific antibody (anti‐NASE) was kindly provided by Dr Pressley (Texas Tech University Health Sciences Center, Lubbock, TX). Polyclonal antibody against early endosome marker Rab5 was from Cell Signaling Technology (Danvers, MA). Polyclonal anti‐Src (pY418) phosphospecific antibody was from Invitrogen (Camarillo, CA). Monoclonal antibodies against total c‐Src and tyrosine phosphorylation (p‐Tyr, clone PY99) were from Santa Cruz (Santa Cruz, CA). 2,4‐Dinitrophenylhydrazine and antibody against 2,4‐dinitrophenyl hydrazone derivatives were from Sigma‐Aldrich. Radioactive \[^3^H\]‐ouabain, ^86^RbCl, and ^22^NaCl were from Perkin Elmer (Shelton, CA).

Cell Cultures {#jah31742-sec-0007}
-------------

Cells were cultured with Dulbecco\'s modified Eagle\'s medium with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin, in a 5% CO~2~‐humidified incubator. Culture medium was changed daily until confluence. Cells were serum‐starved for 16 to 18 hours before treatment. In assays for active transcellular ^22^Na^+^ flux, cells were grown on Transwell^®^ membrane support (Costar Transwell^®^ culture filter inserts, filter pore size: 0.4 μm; Costar, Cambridge, MA) to form monolayers. The transcellular epithelial electrical resistance was measured with EVOM2 Epithelial Voltohmmeter system (World Precision Instruments, Sarasota, FL).

Generation of Mutant Cells {#jah31742-sec-0008}
--------------------------

For the present study, neither a protocol approved by Institutional Review Board nor a protocol approved by institutional Animal Care and Use Committee was required. The wild‐type AAC‐19 cells as well as mutant P224A and A416P cells were all generated from PY‐17 cells by using pRc/CMV1‐rat α1 plasmid that was also kindly provided by Dr Pressley. The PY‐17 is a stable cell line, generated from pig LLC‐PK1 cells, with knockdown of pig α1 by siRNA method. The PY‐17 cells only expressed ≈8% to 10% of pig α1 compared to parent LLC‐PK1 cells.[14](#jah31742-bib-0014){ref-type="ref"}, [15](#jah31742-bib-0015){ref-type="ref"} The pRc/CMV1‐rat α1 plasmid has been used to develop several stable cell lines including rat α1 rescued AAC‐19 (expressing full‐length wild‐type rat α1[14](#jah31742-bib-0014){ref-type="ref"}, [15](#jah31742-bib-0015){ref-type="ref"}) and A416P cells (expressing Ala416/Pro416 mutation in rat α1[16](#jah31742-bib-0016){ref-type="ref"}). The mutant P224A stable cell line (expressing Pro224/Ala224 mutation in rat α1) was generated in the same way as generation of A416P cells. The LLC‐PK1 cells were used to evaluate the total α1 expression level, and the PY‐17 cells were used to evaluate the expression level of endogenous pig α1 in AAC‐19, P224A, and A416P cells.

The Pro222 of pig α1 (UniProtKB/Swiss‐Prot No P05024) in LLC‐PK1 cells corresponds to the Pro224 of the rat α1 (No P06685, Table [1](#jah31742-tbl-0001){ref-type="table-wrap"}). Site‐directed mutagenesis was used to convert Pro224 of rat α1 to generate single Pro224/Ala224 mutation with the QuikChange II Site‐Directed Mutagenesis Kit (Stratagene, Santa Clara, CA). The mutated sequence was confirmed by DNA sequencing. To develop stable cell lines, transfected ouabain‐resistant colonies were selected with ouabain (3 μmol/L) for 1 week post‐transfection to eliminate endogenous ouabain‐sensitive pig α1 as well as untransfected PY‐17 cells because pig α1 subunit is highly sensitive to ouabain compared to rat α1.[17](#jah31742-bib-0017){ref-type="ref"} Survived colonies expressing rat α1 mutants were expanded into single‐cell stable cell lines and verified by specific anti‐rat α1 antibody (anti‐NASE) and \[^3^H\] ouabain binding assay. Wild‐type rat α1‐rescued PY‐17 cell, AAC‐19, was used for control in the following studies.

###### 

Partial Alignment of the α1 Subunit

  ------------------------- ---------------------------------------------
  SP\|P05023\|AT1A1_HUMAN   181 CKVDNSSLTGESEP^224^QTRSPDFTNENPLETR 240
  SP\|P05024\|AT1A1_PIG     179 CKVDNSSLTGESEP^222^QTRSPDFTNENPLETR 238
  SP\|P06685\|AT1A1_RAT     181 CKVDNSSLTGESEP^224^QTRSPDFTNENPLETR 240
  SP\|Q8VDN2\|AT1A1_MOUSE   181 CKVDNSSLTGESEP^224^QTRSPDFTNENPLETR 240
  ------------------------- ---------------------------------------------

The sequences were obtained from UniProtKB*/Swiss‐Prot*.

Isolation of Early Endosome (EE) Fractions {#jah31742-sec-0009}
------------------------------------------

The EE fractions were isolated by sucrose flotation centrifugation, and the enrichment of EE fractions was verified by the EE marker Rab5 as we previously described.[18](#jah31742-bib-0018){ref-type="ref"}, [19](#jah31742-bib-0019){ref-type="ref"} An equal amount of total protein from each sample was precipitated with trichloroacetic acid for Western blot analysis of Na/K‐ATPase α1 and β1 subunits. After immunoblotting with the α1 and β1 subunits, the same membrane was stripped and immunoblotted for Rab5 to serve as loading control. Endocytosed α1 and β1 subunits were normalized by Rab5.

\[^3^H\]‐Ouabain Binding Assay {#jah31742-sec-0010}
------------------------------

To evaluate the cell surface expression level of endogenous pig Na/K‐ATPase α1 subunit, \[^3^H\]‐ouabain binding assay was performed as described before.[16](#jah31742-bib-0016){ref-type="ref"} The \[^3^H\]‐ouabain binding was calibrated with protein content and expressed as the percentage of pig α1 knockdown PY‐17 cells. Each experiment was performed in triplicate.

Enzymatic and Ion‐Exchange Activity Assays {#jah31742-sec-0011}
------------------------------------------

The enzymatic activity of the Na/K‐ATPase was performed by using BIOMOL GREEN Reagent (Enzo Life Science) as described in[16](#jah31742-bib-0016){ref-type="ref"}. Briefly, cells were homogenized, briefly sonicated, and centrifuged (800*g* for 10 minutes) in ice‐cold buffer A (150 mmol/L sucrose, 5 mmol/L HEPES, 4 mmol/L EGTA, 0.8 mmol/L dithiothreitol, pH 7.4). The crude membrane pellet was obtained after centrifugation of the postnuclear fraction (45 000*g* for 45 minutes) and was resuspended in buffer A to determine protein concentration. The crude membrane samples were treated with alamethicin (0.1 mg/mg of protein) for 10 minutes at room temperature and then added to the buffer B (50 mmol/L Tris, 1 mmol/L EGTA, 1 mmol/L MgCl~2~, 25 mmol/L KCl, 100 mmol/L NaCl, 5 mmol/L NaN~3~, pH 7.4). After 15 minutes of pre‐incubation at 37°C, the reaction was started by adding ATP/Mg^2+^ (final concentration of 2 mmol/L) and continued for 45 minutes, and then stopped by adding 8% ice‐cold trichloroacetic acid. Phosphate generated during the ATP hydrolysis was measured by BIOMOL GREEN Reagent. Ouabain‐sensitive Na/K‐ATPase activities were calculated as the difference between the presence and absence of 1 mmol/L ouabain.

To evaluate the transport activity of the Na/K‐ATPase and NHE3, ^86^Rb^+^ and H^+^‐driven ^22^Na^+^ uptake were performed as previously described.[18](#jah31742-bib-0018){ref-type="ref"}, [20](#jah31742-bib-0020){ref-type="ref"} Prior to the initiation of the ^86^Rb^+^ uptake assay, cellular Na^+^ was "clamped" with 20 μmol/L monensin for 15 minutes to assure the measurement of the maximal capacity of total active ^86^Rb^+^ uptake and to minimize the potential effect of changes in intracellular Na^+^. The assay was stopped 10 minutes after adding ^86^Rb^+^ (≈1 μCi/mL medium) by washing 3 times with ice‐cold 100 mmol/L MgCl~2~ solution. In parallel, ouabain‐insensitive ^86^Rb^+^ uptake (pretreated with 2 mmol/L ouabain for 15 minutes) was measured in the presence of monensin. Ouabain‐sensitive ^86^Rb^+^ uptake was calculated by subtraction of ouabain‐insensitive ^86^Rb^+^ uptake from total ^86^Rb^+^ uptake. Prior to H^+^‐driven ^22^Na^+^ uptake assay, cells were pretreated with 50 μmol/L amiloride for 30 minutes to inhibit amiloride‐sensitive NHE1 activity without significant inhibition of NHE3[20](#jah31742-bib-0020){ref-type="ref"}, [21](#jah31742-bib-0021){ref-type="ref"} and Na/K‐ATPase.[22](#jah31742-bib-0022){ref-type="ref"} This allows the measurement of acid‐stimulated Na^+^ entry mainly mediated through apical NHE3. To determine H^+^‐driven ^22^Na^+^ uptake, after treated with or without ouabain (10 μmol/L, 1 hour), cells were first rinsed 3 times with Na^+^‐free buffer (in mmol/L, *N*‐methyl‐[d]{.smallcaps}‐glucamine \[NMDG^+^\] Cl 140, KCl 4, MgCl~2~ 2, CaCl~2~ 1, and HEPES 10, pH 7.4) and acid loaded for 10 minutes in ammonium‐containing Na^+^‐free buffer in which 30 mmol/L NMDG^+^ was replaced with 30 mmol/L NH~4~Cl (in mmol/L, NMDGCl 110, NH~4~Cl 30, KCl 4, MgCl~2~ 2, CaCl~2~ 1, and HEPES 10, pH 7.4). The ^22^Na^+^ uptake was initiated by replacing the NH~4~ ^+^‐containing buffer with Na^+^‐free buffer containing 2 mmol/L ^22^NaCl (≈1 μCi/mL buffer). The ^22^Na^+^ uptake was stopped after 4 minutes by washing 4 times with ice‐cold saline. Each experiment was performed in triplicate.

To determine the effect of ouabain (10 μmol/L, 1 hour) on Na/K‐ATPase transport capacity, cells were pretreated with or without ouabain (10 μmol/L, 1 hour) prior to the assays. Since rat α1 subunit is ouabain‐resistant compared to pig α1 subunit, we chose 10 μmol/L of ouabain that is able to stimulate Na/K‐ATPase/c‐Src signaling in rat RPT primary cultures.[23](#jah31742-bib-0023){ref-type="ref"}

Active Transepithelial ^22^Na^+^ Flux Assay {#jah31742-sec-0012}
-------------------------------------------

Cells were cultured on Transwell^®^ membrane support to form monolayers and pretreated with 50 μmol/L amiloride for 30 minutes to inhibit amiloride‐sensitive NHE1 activity. Active transepithelial ^22^Na^+^ flux (from apical to basolateral compartment) was determined by counting radioactivity in the basolateral aspect 1 hour after ^22^Na^+^ addition to the apical compartment as previously described.[18](#jah31742-bib-0018){ref-type="ref"} Each experiment was performed in triplicate.

To determine the effect of ouabain (10 μmol/L, 1 hour) on transepithelial ^22^Na^+^ transport capacity, cells were pretreated with or without ouabain (10 μmol/L, 1 hour) in basolateral compartments prior to the ^22^Na^+^ flux assay.

Assessment of Phosphorylation of Tyrosine, c‐Src, and ERK1/2 {#jah31742-sec-0013}
------------------------------------------------------------

Cells were treated with and without ouabain (10 μmol/L, 1 hour). Whole cell lysates were prepared with Nonidet P‐40 buffer (containing 1% Nonidet P‐40, 0.25% sodium deoxycholate, 50 mmol/L NaCl, 50 mmol/L HEPES, 10% glycerol \[pH 7.4\], 1 mmol/L sodium vanadate, 0.5 mmol/L sodium fluoride, 1 mmol/L phenylmethanesulfonyl fluoride, and protease inhibitor cocktail for general use \[Sigma‐Aldrich\]). Phosphorylation was determined with anti‐phospho‐tyrosine (p‐Tyr) antibody, anti‐Src (pY418), and anti‐ERK1/2 phosphospecific antibodies. For tyrosine phosphorylation assessment, after immunoblotting for tyrosine phosphorylation, the same membrane was stripped and immunoblotted for actin to serve as loading control. For c‐Src phosphorylation assessment, after immunoblotting for phospho‐c‐Src (p‐Src), the same membrane was stripped and immunoblotted for total c‐Src (t‐Src). Activation of c‐Src was expressed as the ratio of p‐Src/t‐Src with both measurements normalized to 1.0 for the control samples. The assessment of ERK1/2 phosphorylation was performed in the same way as described for c‐Src.

Assessment of Protein Carbonylation {#jah31742-sec-0014}
-----------------------------------

Protein carbonylation was determined by Western blot analysis as we described before.[6](#jah31742-bib-0006){ref-type="ref"} Briefly, an equal amount of total protein from each sample was denatured with 6% SDS (final concentration), derivatized with 2,4‐dinitrophenylhydrazine (freshly prepared, 10 mmol/L in 1 N HCl) to form 2,4‐dinitrophenyl hydrazone derivatives, and then neutralized with neutralization buffer (30% of glycerol in 2 mol/L Tris). This was followed by Western blot for protein carbonylation assay. The signal density values of control samples were normalized to 1.0 with Ponceau S staining as loading control.

Western Blotting {#jah31742-sec-0015}
----------------

For Western blot analysis, equal amounts of total protein were resolved by 10% SDS‐PAGE, transferred onto a polyvinylidene difluoride membrane (EMD Millipore), and immunoblotted with indicated antibodies. Signal detection was performed with an enhanced chemiluminescence SuperSignal kit (Pierce, Rockford, IL). Multiple exposures were analyzed to assure that the signals were within the linear range of the film. The signal density was determined using NIH ImageJ 1.48v software.

Bioinformatics Analysis of the Pro222 of the Na/K‐ATPase {#jah31742-sec-0016}
--------------------------------------------------------

DeepView‐Swiss‐PdbViewer (v4.1) integrated with SWISS‐MODEL via the ExPASy web server, a fully automated protein structure homology‐modeling server used to generate a 3‐dimensional structure of a protein from its amino acid sequence.[24](#jah31742-bib-0024){ref-type="ref"} Modeling of pig Na/K‐ATPase E1P and E2P structures was based on 3WGU[25](#jah31742-bib-0025){ref-type="ref"} and 4RES[26](#jah31742-bib-0026){ref-type="ref"} pdb structures, respectively. The pig c‐Src kinase crystal structure was derived from pdb 1Y57.[27](#jah31742-bib-0027){ref-type="ref"} The rat Na/K‐ATPase E1P and E2P structures were derived from 3WGU and 4RES. The alignment of pig and rat Na/K‐ATPase α1 subunit showed over 98% sequence similarity. The quality of structures was further assessed by using *S*tructure *A*nalysis and *V*erification *S*erver (v4). The protein--protein docking analysis was performed by using Z‐DOCK web server[28](#jah31742-bib-0028){ref-type="ref"} and the protein--protein interaction was visualized by using Accelrys Discovery Studio Visualizer v2.5.5.

Statistical Analysis {#jah31742-sec-0017}
--------------------

Data were tested for normality (by SPSS Shapiro--Wilk normality test) and then subjected to parametric analysis. When more than 2 groups were compared, 1‐way ANOVA was performed prior to comparison of individual groups, and the post‐hoc *t* tests were adjusted for multiple comparisons using Bonferroni\'s correction. Statistical significance was reported at the *P*\<0.05 and \<0.01 levels. SPSS software was used for all analysis. Values are given as mean±SEM.

Results {#jah31742-sec-0018}
=======

Generation of Stable P224A Mutant Cells {#jah31742-sec-0019}
---------------------------------------

As shown in Figure [1](#jah31742-fig-0001){ref-type="fig"}, P224A mutant cells expressed a slightly higher but relatively comparable level of mutated rat α1 in comparison with AAC‐19 cells. The expression of rat α1 was confirmed by a rat α1‐specific antibody (anti‐NASE), and the total α1 (both endogenous pig α1 and rat α1) with a generic α1‐specific antibody α6F (Figure [1](#jah31742-fig-0001){ref-type="fig"}A). The expression of mutated rat α1 in P224A mutant cells was predominantly located on the cell surface assayed by immunofluorescence staining of α1 subunit (data not shown), like AAC‐19 and A416P cells.[16](#jah31742-bib-0016){ref-type="ref"} The P224A mutant also expressed a relatively comparable level of β1 subunit in comparison with AAC‐19 cells (Figure [1](#jah31742-fig-0001){ref-type="fig"}B). The blots were intended to show possible expression difference between AAC‐19 and P224A cells, but not to compare the expression of the α1 subunit to the β1 subunit. \[^3^H\]‐ouabain binding assay was used to assess the cell surface expression level of endogenous pig α1 subunit in the mutant P224A and A416P cells. The significant lower affinity of ouabain to the rat α1, compared to the much higher affinity of ouabain to the pig α1, makes it possible to assess the surface expression of pig α1 in the presence of rat α1. In comparison to pig α1 knockdown PY‐17 cells, which express about 8% of endogenous pig α1 in parent LLC‐PK1 cells, AAC‐19, P224A, and A416P cells showed significantly lower \[^3^H\]‐ouabain binding level (Figure [1](#jah31742-fig-0001){ref-type="fig"}C). A lower \[^3^H\]‐ouabain binding level in P224A mutant cells suggests a further reduction of endogenous pig α1 subunit compared to PY‐17 cells. It is worth noting that PY‐17 cells had disrupted Na/K‐ATPase/c‐Src signaling and did not respond to ouabain stimulation in terms of c‐Src activation,[15](#jah31742-bib-0015){ref-type="ref"}, [17](#jah31742-bib-0017){ref-type="ref"} suggesting that the remaining endogenous pig α1 would not interfere with ouabain‐mediated signaling and function originated from rat α1 in AAC‐19 and mutant P224A and A416P cells. Functionally, the mutant P224A and A416P cells showed a similar sensitivity to ouabain as AAC‐19 cells, in terms of ouabain‐sensitive enzymatic activity of the Na/K‐ATPase in crude membrane preparations (Figure [1](#jah31742-fig-0001){ref-type="fig"}D) as well as the ion‐exchange activity assayed by ouabain‐sensitive ^86^Rb^+^ uptake (Figure [1](#jah31742-fig-0001){ref-type="fig"}E). The data indicate that P224A mutation did not change the characteristics of ouabain‐induced Na/K‐ATPase inhibition.

![Expression of Na/K‐ATPase in P224A mutation. A and B, P224A mutant cells express mutated rat α1 and β1 subunits. Expression of the rat α1 Na/K‐ATPase was determined with polyclonal rat α1‐specific antibody (anti‐NASE) (n=4) and the total α1 was determined with monoclonal anti‐α1 antibody (clone α6F) (n=3). Expression of endogenous pig β1 subunit (glycosylated) was determined with monoclonal anti‐β1 antibody (clone C464.8) (n=4) and the blots were optimized to show possible difference. A representative Western blot and quantitative analysis were shown. Quantitative analysis (bar graph) showed the relative expression of α1 and β1 subunits to control wild‐type AAC‐19 (for rat α1 and β1), and LLC‐PK1 (for total α1) cells. \*\**P*\<0.01 vs control AAC‐19 cells. C, \[^3^H\]‐ouabain binding assay (control value, PY‐17 cells, 922.8±82.1 CPM/100 μg protein), n=4. \*\**P*\<0.01, \**P*\<0.05 vs parent PY‐17 cells. (D) Ouabain‐sensitive Na/K‐ATPase enzymatic activity (control values, in μmol/L·(mg protein·h)^−1^. AAC‐19, 0.953±0.220, n=4; P224A, 2.074±0.169, n=3; and A416P 0.855±0.153, n=4), and (E) ouabain‐sensitive ^86^Rb^+^ uptake assays (control values, in CPM/100 μg protein. AAC‐19, 10 913.9±1356, n=4; P224A, 14 975.7±2149, n=4; and A416P 13 426.9±1440, n=4). For (C through E), each experiment was performed in triplicate. The values shown were from a typical experiment.](JAH3-5-e003675-g001){#jah31742-fig-0001}

Ouabain‐Stimulated Protein Tyrosine Phosphorylation {#jah31742-sec-0020}
---------------------------------------------------

In a different type of cells, ouabain stimulated tyrosine phosphorylation of multiple proteins in a c‐Src‐dependent manner that is crucial in ouabain‐stimulated Na/K‐ATPase signaling.[13](#jah31742-bib-0013){ref-type="ref"}, [29](#jah31742-bib-0029){ref-type="ref"} In contrast to c‐Src reconstituted SYF+c‐Src cells, depletion of Src family kinases (Src, Yes, and Fyn) prevented ouabain (10--100 μmol/L)‐induced protein tyrosine phosphorylation[13](#jah31742-bib-0013){ref-type="ref"} and Na/K‐ATPase endocytosis in SYF cells.[19](#jah31742-bib-0019){ref-type="ref"} As shown in Figure [2](#jah31742-fig-0002){ref-type="fig"}, ouabain (10 μmol/L, 1 hour) significantly stimulated tyrosine phosphorylation of multiple proteins in AAC‐19 (*P*\<0.01) and A416P (*P*\<0.01), but not in P224A cells, suggesting that P224A mutation might prevent ouabain‐mediated Na/K‐ATPase signaling.

![P224A mutation prevents ouabain‐stimulated protein tyrosine phosphorylation: Ouabain (10 μmol/L, 1 hour)‐stimulated protein tyrosine phosphorylation in AAC‐19 and A416P mutant cells, but not in P224A mutant cells. A representative Western blot and quantitative analysis were shown. n=4. \*\**P*\<0.01 vs control.](JAH3-5-e003675-g002){#jah31742-fig-0002}

Ouabain‐Stimulated Protein Carbonylation and Na/K‐ATPase Signaling {#jah31742-sec-0021}
------------------------------------------------------------------

As shown in Figure [3](#jah31742-fig-0003){ref-type="fig"}, ouabain (10 μmol/L, 1 hour) significantly stimulated (*P*\<0.01) protein carbonylation of a broad range of proteins in AAC‐19 and A416P but not in P224A cells (Figure [3](#jah31742-fig-0003){ref-type="fig"}A). The P224A mutation significantly (*P*\<0.01) attenuated ouabain (10 μmol/L, 1 hour)‐stimulated c‐Src and ERK1/2 activation as seen in AAC‐19 and A416P mutant cells (Figure [3](#jah31742-fig-0003){ref-type="fig"}B and [3](#jah31742-fig-0003){ref-type="fig"}C). The ouabain‐induced effects in AAC‐19 and A416P cells were similar to that seen in LLC‐PK1 cells.[6](#jah31742-bib-0006){ref-type="ref"} These data indicate that Pro224 of the rat α1 subunit might be essential in ouabain‐stimulated protein carbonylation and Na/K‐ATPase signaling.

![P224A mutation prevents ouabain‐stimulated protein carbonylation and Na/K‐ATPase signaling. Ouabain (Oua, 10 μmol/L, 1 hour)‐stimulated protein (A) protein carbonylation (n=5 for AAC‐19, n=6 for P224A, and n=4 for A416P cells), (B) activation of c‐Src (n=4), and (C) activation of ERK1/2 (n=5 for AAC‐19, and n=4 for P224A and A416P cells) in control AAC‐19 and mutant A416P cells, but not in P224A cells. Ponceau S staining served as loading control for carbonylation. Activation of c‐Src and ERK1/2 was expressed as the ratio of phosphorylated c‐Src (p‐Src) vs total c‐Src (t‐Src) and the ratio of phosphorylated ERK1/2 (p‐ERK) vs total ERK1/2 (t‐ERK), respectively. \*\**P*\<0.01 vs control. AAC‐19 and P224A cells were performed side by side in the same gels, and A416P cells were performed in separated gels. DNP indicates the derivatives of DNPH reaction, i.e. carbonylation.](JAH3-5-e003675-g003){#jah31742-fig-0003}

Ouabain‐Induced Endocytosis of Na/K‐ATPase {#jah31742-sec-0022}
------------------------------------------

As shown in Figure [4](#jah31742-fig-0004){ref-type="fig"}, in AAC‐19 cells, both ouabain (10 μmol/L, 1 hour) and glucose oxidase (GO, 3 mU/mL, 1 hour) stimulated accumulation of Na/K‐ATPase α1/β1 subunits in EE fractions (*P*\<0.01), which is consistent with our previous observations in LLC‐PK1 cells and rat RPTs.[18](#jah31742-bib-0018){ref-type="ref"}, [19](#jah31742-bib-0019){ref-type="ref"}, [23](#jah31742-bib-0023){ref-type="ref"} However, ouabain‐induced endocytosis of Na/K‐ATPase was significantly attenuated (*P*\<0.01) with the P224A mutation. Functionally, the data are consistent with the observation that ouabain (10 μmol/L, 1 hour)‐induced inhibition of active transepithelial ^22^Na^+^ flux was blunted by the P224A mutation (Table [2](#jah31742-tbl-0002){ref-type="table-wrap"}). It is worth noting that both ouabain‐ and glucose oxidase--stimulated Na/K‐ATPase endocytosis was prevented by the P224A mutation, consistent with our previous observation in Src kinase null SYF cells.[6](#jah31742-bib-0006){ref-type="ref"}

![P224A mutation prevents ouabain‐induced Na/K‐ATPase endocytosis. P224A mutation prevents ouabain (10 μmol/L, 1 hour)‐stimulated accumulation of α1 and β1 subunit in early endosome fractions. A representative Western blot and quantitative analysis were shown. n=4, \*\**P*\<0.01 vs control AAC‐19 cells.](JAH3-5-e003675-g004){#jah31742-fig-0004}

###### 

Ouabain (10 μmol/L, 1 Hour)‐Inhibited Activities of Na/K‐ATPase and NHE3 as Well as Active Transepithelial ^22^Na^+^ Flux in AAC‐19 and A416P Cells, but Not in P224A Mutant Cells

                                   AAC‐19    P224A                                                A416P                           
  -------------------------------- --------- ---------------------------------------------------- --------- ----------- --------- ----------------------------------------------------
  ^86^Rb^+^ uptake                 100±6.1   76.4±5.5[\*\*](#jah31742-note-0003){ref-type="fn"}   100±3.1   101.9±3.6   100±4.4   80.4±4.2[\*](#jah31742-note-0003){ref-type="fn"}
  H^+^‐driven ^22^Na^+^ uptake     100±4.6   69.7±3.7[\*\*](#jah31742-note-0003){ref-type="fn"}   100±5.3   101.0±3.1   100±5.0   71.1±4.5[\*\*](#jah31742-note-0003){ref-type="fn"}
  Transepithelial ^22^Na^+^ flux   100±4.7   72.5±5.5[\*\*](#jah31742-note-0003){ref-type="fn"}   100±6.7   98.1±3.4    100±5.1   72.3±3.7[\*\*](#jah31742-note-0003){ref-type="fn"}

After treatment with or without ouabain (10 μmol/L, 1 hour), assays were performed as described in "Enzymatic and Ion‐Exchange Activity Assays" and "Active Transepithelial 22Na+ Flux Assay" under "Experimental Methods." For ouabain‐sensitive ^86^Rb^+^ uptake assay, the control values are (in CPM/100 μg protein) AAC‐19, 10 913.9±1356; P224A, 14 975.7±2149; and A416P, 13 426.9±1440. For H^+^‐driven ^22^Na^+^ uptake assay, the control values are (in CPM/100 μg protein) AAC‐19, 1721.8±138.7; P224A, 2274.7±109.5; and A416P, 1764.4±150.8. For active transepithelial ^22^Na^+^ flux assay, 60 minutes after ^22^Na^+^ was added to the apical compartments, medium from basolateral compartments from each well was collected and counted. The control values are AAC‐19, 3236.4±237.7; P224A, 3794.6±219.7; and A416P, 3479.4±250.8. The transepithelial electrical resistance (TER, in Ω·cm^2^) of monolayers was measured in culture medium and calculated by subtracting the resistance measured with the blank insert. The control TER values (in Ω·cm^2^) are AAC‐19, 70.8±5.6; P224A, 144.6±8.9; and A416P, 96.9±7.8. Each experiment was performed in triplicate. The control values shown were from a typical experiment. n=3 to 4.

\**P*\<0.05 and \*\**P*\<0.01 vs control.

Ouabain‐Induced Reduction of Transepithelial ^22^Na^+^ Transport {#jah31742-sec-0023}
----------------------------------------------------------------

In pig LLC‐PK1 cells and rat proximal tubular cells, ouabain treatment stimulated internalization of the Na/K‐ATPase and NHE3 via the Na/K‐ATPase signaling. This led to the reduction of the Na/K‐ATPase and NHE3 on the cell surface, which further led to reduced Na^+^ entry (mainly mediated by NHE3) and Na^+^ extrusion (mainly mediated by the Na/K‐ATPase) and thus reduced active transepithelial ^22^Na^+^ transport of the cells.[18](#jah31742-bib-0018){ref-type="ref"}, [19](#jah31742-bib-0019){ref-type="ref"}, [23](#jah31742-bib-0023){ref-type="ref"}, [30](#jah31742-bib-0030){ref-type="ref"}, [31](#jah31742-bib-0031){ref-type="ref"}, [32](#jah31742-bib-0032){ref-type="ref"} To evaluate the effect of the mutation of P224A and A416P on Na/K‐ATPase‐mediated Na^+^ extrusion (by ^86^Rb^+^ uptake assay), NHE3‐mediated Na^+^ entry (by H^+^‐driven ^22^Na^+^ uptake assay) and active transepithelial ^22^Na^+^ transport (by active transepithelial ^22^Na^+^ flux assay), AAC‐19, P224A, and A416P cells were treated with or without ouabain (10 μmol/L, 1 hour) and then the assays were performed. As shown in Table [2](#jah31742-tbl-0002){ref-type="table-wrap"}, ouabain significantly inhibited the cellular Na^+^ entry and extrusion as well as transepithelial ^22^Na^+^ transport in AAC‐19 and A416P cells, but not in P224A cells. The data indicate that, while ouabain was able to stimulate similar functional changes in AAC‐19 and A416P cells, as seen in LLC‐PK1 and renal RPTs,[18](#jah31742-bib-0018){ref-type="ref"}, [23](#jah31742-bib-0023){ref-type="ref"} the P224A mutation prevented ouabain‐mediated regulation. However, we could not exclude the possible effect of chloride‐couple cation carriers and K^+^ channels.

Bioinformatics Analysis of the Pro222 of the Na/K‐ATPase {#jah31742-sec-0024}
--------------------------------------------------------

The bioinformatics analysis indicated that pig Pro222 carbonylation and Ala222 in Pro/Ala mutation did not affect tertiary structure. In comparison to Pro222, carbonylated Pro222 might bind more strongly to c‐Src SH2 domain in E1P state. Before carbonylation, both Pro222 and Ala222 were able to bind to Tyr244 of c‐Src SH2 domain. After carbonylation, Pro222 was able to bind to Tyr244 as well as other amino acid residues of c‐Src SH2 domain, including Asn208, Asn236, and His248. When the α1 CD2 segment (amino acid residues 152--288) and ND1 segment (amino acid residues 379--435)[13](#jah31742-bib-0013){ref-type="ref"}, [33](#jah31742-bib-0033){ref-type="ref"} were used for docking analysis, it was predicted that CD2 will bind to the c‐Src SH2 domain (amino acid residues 161--251) in both E1P and E2P state, and this appears to be further enhanced by Pro222 carbonylation. However, the ND1 can bind to the c‐Src tyrosine kinase domain (amino acid residues 282--531) with many more posses in E1P state than in E2P state. During the E1P to E2P conformation change, the internal distance between the ND1 to pro222 in the α1 subunit was changed, as indicated by the yellow double‐headed arrow (Figure [5](#jah31742-fig-0005){ref-type="fig"}, left and right panel), from 24.829 Å in E1P state to 6.340 Å in E2P state. Furthermore, docking analysis with Pro224 and Ala224 in Pro/Ala mutation of rat α1 showed the same predictions as seen in pig α1.

![Illustration of the 3‐dimensional structure of the Na/K‐ATPase α1 subunit in E1P state (left panel), E2P state (right panel), and Pro222 (middle panel). From upper to lower images, Pro222, carbonylated 222, and Ala222 in Pro/Ala mutation in E1P state.](JAH3-5-e003675-g005){#jah31742-fig-0005}

Discussion {#jah31742-sec-0025}
==========

As an ion pump, the physiological function of the Na/K‐ATPase is to maintain the electrochemical sodium gradient and cellular sodium homeostasis at the expense of ATP. Recent studies have demonstrated that Na/K‐ATPase also functions as a signal transducer through multiple protein--protein interactions.[13](#jah31742-bib-0013){ref-type="ref"}, [33](#jah31742-bib-0033){ref-type="ref"}, [34](#jah31742-bib-0034){ref-type="ref"} At physiological concentrations, binding of cardiotonic steroids such as ouabain (at low concentration without significant inhibition of Na/K‐ATPase transport activity) to the Na/K‐ATPase α1 subunit results in the activation of Src, transactivation of epidermal growth factor receptor (EGFR), assembly of multiple protein kinase cascades, and increases in ROS and intracellular calcium (reviewed in[33](#jah31742-bib-0033){ref-type="ref"}, [34](#jah31742-bib-0034){ref-type="ref"}, [35](#jah31742-bib-0035){ref-type="ref"}, [36](#jah31742-bib-0036){ref-type="ref"}). The activation of the Na/K‐ATPase signaling function is largely independent of the changes in intracellular sodium concentration and significant acute inhibition of Na/K‐ATPase transport activity. Functionally, this activation leads to redistribution of Na/K‐ATPase and NHE3 in the RPT, resulting in a decrease in surface contents of these 2 transporters and consequently a reduction in RPT sodium reabsorption.[18](#jah31742-bib-0018){ref-type="ref"}, [19](#jah31742-bib-0019){ref-type="ref"}, [23](#jah31742-bib-0023){ref-type="ref"}, [30](#jah31742-bib-0030){ref-type="ref"}, [31](#jah31742-bib-0031){ref-type="ref"}, [34](#jah31742-bib-0034){ref-type="ref"}, [37](#jah31742-bib-0037){ref-type="ref"}, [38](#jah31742-bib-0038){ref-type="ref"}

Our in vitro data suggest that direct carbonylation modification of the Pro222 residue in pig Na/K‐ATPase α1 subunit might be a novel regulatory mechanism of Na/K‐ATPase signaling.[6](#jah31742-bib-0006){ref-type="ref"} The Pro residue and α1 subunit are highly conserved (Table [1](#jah31742-tbl-0001){ref-type="table-wrap"}). To verify the function of Pro222 carbonylation of pig α1 subunit in our previous observation,[6](#jah31742-bib-0006){ref-type="ref"} we chose the equivalent Pro224 of rat α1 subunit to assess its role in ouabain‐mediated Na/K‐ATPase signaling and subsequent regulation of sodium transport. We constructed the Pro224 to Ala224 (P224A) and Ala416 to Pro416 (A416P) mutants based on a rat α1 cDNA expressing vector as we described before.[16](#jah31742-bib-0016){ref-type="ref"}, [17](#jah31742-bib-0017){ref-type="ref"} Using PY‐17 cells, which were derived from pig LLC‐PK1 cells with an over 90% knockdown of pig α1 subunit, the ouabain‐sensitive endogenous pig α1 subunit was rescued with ouabain‐resistant rat α1 subunit.[17](#jah31742-bib-0017){ref-type="ref"} The remaining pig α1 subunit was further reduced by post‐transfection selection with ouabain. Wild‐type rat α1‐rescued PY‐17 cells (AAC‐19)[17](#jah31742-bib-0017){ref-type="ref"} were used as a control. The stable P224A mutant cells (clone 9G3, abbreviated as P224A) and A416P mutant cells (clone 4, abbreviated as A416P) were selected for the following experiments. The establishment and characterization of AAC‐19 and A416P cells were described before.[16](#jah31742-bib-0016){ref-type="ref"}, [17](#jah31742-bib-0017){ref-type="ref"} A416 is located in the nucleotide binding (N) domain of the α1 subunit. Expression of A416P mutant in PY‐17 cells showed similar characteristics of AAC‐19 cells, such as α1 and caveolin‐1 expressions, ouabain‐sensitive Na/K‐ATPase activity as well as basal and ouabain‐mediated c‐Src activation.[16](#jah31742-bib-0016){ref-type="ref"} We reasoned that the A416P mutation can serve as a mutant control.

There are significant differences in sensitivity of the Na/K‐ATPase to ouabain based on α isoforms and species.[39](#jah31742-bib-0039){ref-type="ref"}, [40](#jah31742-bib-0040){ref-type="ref"} Specifically, the rodent α1 is far less sensitive than pig, dog, or human α1, largely because of the low affinity of ouabain to rodent α1. A higher concentration of ouabain (10 μmol/L) is needed to activate Na/K‐ATPase‐c‐Src cascade and induce Na/K‐ATPase endocytosis in primary culture of RPTs isolated from Dahl salt‐resistant rats[23](#jah31742-bib-0023){ref-type="ref"} and AAC‐19 cells.[32](#jah31742-bib-0032){ref-type="ref"} Since rat α1 is ouabain resistant, the following experiments were performed with 10 μmol/L ouabain in AAC‐19 and mutant cells, which is capable of activating rat Na/K‐ATPase signaling without significantly affecting the transport and enzymatic activity of the Na/K‐ATPase.[18](#jah31742-bib-0018){ref-type="ref"}, [32](#jah31742-bib-0032){ref-type="ref"}, [38](#jah31742-bib-0038){ref-type="ref"}

Our present data demonstrated that altering carbonylation modification of Pro224 of the rat α1 subunit is able to alter Na/K‐ATPase signaling and sodium handling. Rather than contributing to development and maintenance of hypertension, properly regulated RPT Na/K‐ATPase signaling has a protective effect under physiological settings.[23](#jah31742-bib-0023){ref-type="ref"}, [31](#jah31742-bib-0031){ref-type="ref"} The impaired RPT Na/K‐ATPase/c‐Src signaling in Dahl salt‐sensitive rats[23](#jah31742-bib-0023){ref-type="ref"} prompted us to investigate the role of oxidative modification in regulation of Na/K‐ATPase signaling and function[6](#jah31742-bib-0006){ref-type="ref"} since an increase in oxidative stress is both a cause and consequence of hypertension[41](#jah31742-bib-0041){ref-type="ref"}, [42](#jah31742-bib-0042){ref-type="ref"}, [43](#jah31742-bib-0043){ref-type="ref"}, [44](#jah31742-bib-0044){ref-type="ref"}, [45](#jah31742-bib-0045){ref-type="ref"} and contributes to salt sensitivity.[46](#jah31742-bib-0046){ref-type="ref"}, [47](#jah31742-bib-0047){ref-type="ref"}

In LLC‐PK1 cells, ROS is a critical signaling mediator of ouabain‐mediated RPT Na/K‐ATPase/c‐Src signal transduction.[6](#jah31742-bib-0006){ref-type="ref"} Specifically, carbonylation modification of Pro222 of the pig α1 subunit is involved in the regulation of Na/K‐ATPase signal transduction and subsequent inhibition of transepithelial ^22^Na^+^ flux. The present data further indicated that carbonylation modification of the Pro224 of rat α1 subunit is not only a key regulator but also functions as a signaling amplifier in ouabain‐mediated Na/K‐ATPase signals and sodium handling. Moreover, ouabain‐induced ROS generation and carbonylation modification may function as the link from ouabain‐Na/K‐ATPase signaling to NHE3 regulation.[6](#jah31742-bib-0006){ref-type="ref"}

An increase in ROS, either induced by ouabain or glucose oxidase, stimulated Src kinase tyrosine phosphorylation[48](#jah31742-bib-0048){ref-type="ref"} and reduced protein content of Na/K‐ATPase and NHE3 on the cell surface.[6](#jah31742-bib-0006){ref-type="ref"}, [8](#jah31742-bib-0008){ref-type="ref"}, [13](#jah31742-bib-0013){ref-type="ref"} In LLC‐PK1 cells, ouabain‐mediated inhibition of transepithelial ^22^Na^+^ flux was largely dependent on the coordinated regulation of basolateral Na/K‐ATPase and apical NHE3 through Na/K‐ATPase signaling.[18](#jah31742-bib-0018){ref-type="ref"}, [32](#jah31742-bib-0032){ref-type="ref"}, [49](#jah31742-bib-0049){ref-type="ref"} In LLC‐PK1 cells, ouabain reduces cell surface Na/K‐ATPase and NHE3 that leads to reduced apical Na^+^ entry through NHE3 and basolateral Na^+^ extrusion through Na/K‐ATPase. Disruption of the Na/K‐ATPase/c‐Src signaling (as seen in pig α1 knockdown PY‐17 cells, caveolin‐1 knockout C2‐9 cells, and Src kinase null SYF cells) attenuated ouabain‐stimulated protein carbonylation.[6](#jah31742-bib-0006){ref-type="ref"} In control AAC‐19 and mutant A416P cells, ouabain‐induced inhibition of transepithelial ^22^Na^+^ flux was related to the Na/K‐ATPase signaling and carbonylation modification. The present study is consistent with our observations in LLC‐PK1 cells, suggesting that the Pro224 is a critical mediator of ouabain‐stimulated Na/K‐ATPase signaling. Functionally, the P224A mutation prevents ouabain‐induced Na/K‐ATPase signaling, protein carbonylation, and inhibition of transepithelial ^22^Na^+^ flux, further demonstrating the involvement of Pro224 and carbonylation modification in ouabain‐mediated effects. The present data strengthen our hypothesis that carbonylation modification of the Pro residue is a novel regulator and an amplifier of Na/K‐ATPase signaling and functions. Furthermore, these data support the hypothesis that the Na/K‐ATPase/c‐Src signaling complex is capable of functioning as a receptor complex of ROS by oxidative modification of the Na/K‐ATPase α1 subunit like carbonylation.

It is well documented that ouabain and other stimuli stimulated c‐Src activation. It has been proposed that the Na/K‐ATPase α1 subunit interacts with c‐Src kinase to form a functional Na/K‐ATPase/c‐Src signaling receptor complex.[13](#jah31742-bib-0013){ref-type="ref"}, [33](#jah31742-bib-0033){ref-type="ref"} In this model, the Na/K‐ATPase α1 subunit provides the ligand binding site and the associated c‐Src functions as the kinase moiety. It has also been proposed that c‐Src activation is primarily due to an ATP‐sparing effect based on a cell‐free system.[50](#jah31742-bib-0050){ref-type="ref"}, [51](#jah31742-bib-0051){ref-type="ref"} While the Na/K‐ATPase inhibitors (vanadate and oligomycin) and ATP/ADP ratio regulate c‐Src activation, a possible interaction between the α1 and c‐Src was not addressed.[50](#jah31742-bib-0050){ref-type="ref"}, [51](#jah31742-bib-0051){ref-type="ref"}

There are some additional data that are at odds with our model. It has been shown that ouabain did not induce interaction between the α1 and c‐Src by immunoprecipitation assay in human breast tumor and nontumorigenic cells[52](#jah31742-bib-0052){ref-type="ref"} and ouabain‐induced α1 endocytosis was independent of c‐Src activation or PI(3)K in non--small cell lung carcinoma cells.[53](#jah31742-bib-0053){ref-type="ref"} We would point out that these observations are different from those that we have reported in purified pig Na/K‐ATPase, primary RPT, SYF and SYF+c‐Src, pig LLC‐PK1, rat α1 rescued LLC‐PK1, human HK‐2, primary culture of human dermal fibroblasts, primary culture of rat cardiac fibroblasts, and a renal fibroblast cell line.[1](#jah31742-note-1001){ref-type="fn"} Therefore, we do believe that the Na/K‐ATPase‐Src model is worthy of further exploration. Of course, it is possible that the c‐Src can be activated by other mechanisms and the Na/K‐ATPase conformation change is the key step in regulating the endocytosis of this complex, per se.

Our bioinformatic analysis predicted that in pig α1 subunit, Pro222 carbonylation and Pro222/Ala mutation would not affect the enzymatic function of the Na/K‐ATPase, and based on our experimental results, enzymatic function and ouabain sensitivity were unchanged by this mutation. Carbonylation of Pro222 provided more interaction possibilities with c‐Src SH2 domain than native Pro222 in E1P state, favoring the interaction between the CD2 domain of α1 subunit and c‐Src SH2 domain. It was also predicted that, while the α1 CD2 binds to the c‐Src SH2 domain in both E1P and E2P state, which was further enhanced by Pro222 carbonylation, the α1 ND1 binds to c‐Src tyrosine kinase domain with more possibilities in E1P state than in E2P state. This suggests that carbonylation might shift a balance between SH2 domain and tyrosine kinase domain binding to the former state, allowing for greater activity of the kinase. However, it is still unclear whether this effect of carbonylation of Pro222 leads to a shift from the E1P→E2P state or whether another mechanism is operant. As prevention of carbonylation at this site by our site mutation prevented activation of c‐Src by ouabain, we believe that this carbonylation site may be important in the generation of signals by cardiotonic steroids. We would further speculate that the carbonylation of Pro222 might affect interactions between the α1 subunit and other signaling partners such as PI3K and the IP3R.[56](#jah31742-bib-0056){ref-type="ref"} However, these predictions need to be further investigated.

Prospectively, carbonylation modification of the Na/K‐ATPase, induced by cardiotonic steroids and/or other stimuli, might be important in renal sodium handling. In the kidney, an increase in oxidative stress influenced a number of physiologic processes as aforementioned, including renal sodium handling.[57](#jah31742-bib-0057){ref-type="ref"}, [58](#jah31742-bib-0058){ref-type="ref"}, [59](#jah31742-bib-0059){ref-type="ref"}, [60](#jah31742-bib-0060){ref-type="ref"}, [61](#jah31742-bib-0061){ref-type="ref"} In RPTs in particular, increases in oxidative stress inhibited the activity of Na/K‐ATPase and NHE3 to promote RPT sodium excretion under certain circumstances.[57](#jah31742-bib-0057){ref-type="ref"}, [59](#jah31742-bib-0059){ref-type="ref"}, [60](#jah31742-bib-0060){ref-type="ref"} Future studies will be necessary to investigate the role and mechanism of Na/K‐ATPase carbonylation in renal sodium handling, especially the reversible carbonylation modification as we have previously observed.[6](#jah31742-bib-0006){ref-type="ref"}

Sources of Funding {#jah31742-sec-0026}
==================

Portions of this work were supported by NIH RO1 HL‐109015 (to Z.‐j. Xie and J.I. Shapiro), HL071556 (to J.I. Shapiro), and RO1 HL‐105649 to (J. Tian and J.I. Shapiro).

Disclosures {#jah31742-sec-0027}
===========

None.

References [2](#jah31742-bib-0002){ref-type="ref"}, [5](#jah31742-bib-0005){ref-type="ref"}, [6](#jah31742-bib-0006){ref-type="ref"}, [13](#jah31742-bib-0013){ref-type="ref"}, [14](#jah31742-bib-0014){ref-type="ref"}, [18](#jah31742-bib-0018){ref-type="ref"}, [19](#jah31742-bib-0019){ref-type="ref"}, [23](#jah31742-bib-0023){ref-type="ref"}, [30](#jah31742-bib-0030){ref-type="ref"}, [32](#jah31742-bib-0032){ref-type="ref"}, [54](#jah31742-bib-0054){ref-type="ref"}, [55](#jah31742-bib-0055){ref-type="ref"}.
